Kohjin Bio, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 86%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Feb 14, 2025 3:30 pm JST Earnings

177A Kohjin Bio Co.,Ltd. 【J-GAAP】

Earnings Report

Kohjin Bio Co.,Ltd. <177A> [TSE Growth] announced its financial results after the market closed on February 14th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) expanded 740 million yen, an increase 86.4% compared to the same period last year. The progress rate toward the full-year plan of 876 million yen was 84.5%, also surpassing the progress rate of 62.5% from the same period of the previous year.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to drop 42.9% from the same period last year to 136 million yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit decreased to 324 million yen, a 11.7% decrease compared to the same period last year. The operating profit margin decreased from 27.3% in the same period last year to 20.9%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2024	3,923	675	740	516	103.0	84.5	Feb 14, 2025	J-GAAP
YoY	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	2,559	590	605	442	106.4	14	May 15, 2024	J-GAAP
Oct - Mar, 2024 Guidance	2,345	478	460	352	68.9	14	Nov 14, 2024	J-GAAP
YoY	-8.4%	-19.0%	-24.0%	-20.4%	-35.3%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2024	4,770	596	635	384	92.4	14	May 15, 2024	J-GAAP
Mar, 2025 Guidance	4,852	857	876	629	123.1	14	May 15, 2024	J-GAAP
YoY	+1.7%	+43.8%	+38.0%	+63.8%	+33.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	1,226	226	238	177	42.6	18.4	May 15, 2024	J-GAAP
Apr - Jun, 2024	1,241	206	225	162	33.6	16.6	Aug 14, 2024	J-GAAP
Jul - Sep, 2024	1,266	173	191	115	23.1	13.7	Nov 14, 2024	J-GAAP
Oct - Dec, 2024	1,416	296	324	239	47.7	20.9	Feb 14, 2025	J-GAAP
YoY	－	－	－	－	－